NEJM
New England Journal of Medicine
NEJM
Clinician
NEJM
Evidence
NEJM
AI
NEJM
Catalyst
NEJM
Voices
Loading...
Week Of
November 2nd
A New Face … and New Findings
Curated by the NEJM Clinician Editors
Stay Informed
Letter to Readers
Free
Meet Our New Editor-in-Chief
Dr. Paul Sax tells us a little bit about himself — and why he’s excited to lead NEJM Clinician.
Guideline Watch
An Updated Guideline on Tinnitus
Journal Watch
Is Carvedilol Really the Best Nonselective Beta-Blocker in Cirrhosis?
Journal Watch
Antidepressant Effects on the QTc Interval: Clinical Implications
Drug Watch
Finerenone Now Approved for Renal Protection in Type 1 Diabetes
Journal Watch
Hearing Aids for Dementia Prevention: A Null Trial but Not a Closed Case
Drug Watch
mRNA Flu Vaccine Licensed in the U.S.
Journal Watch
A Spoonful of Honey for a Child’s Cough
Build Your Knowledge
Review Article
Adult Attention-Deficit/Hyperactivity Disorder
NEJM Images in Clinical Medicine
Thelaziasis
End of This Week's Edition
See you for our next edition the week of
November 9th.
Until then, we welcome your
feedback
.
More from NEJM Clinician
Previous Editions
By Specialty
By Topic
Browse All